Stock Market Reviews

Read and share opinions on AYTU (Aytu BioPharma, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

Latest News

• Aytu BioPharma Inc (AYTU) Q1 2026 Earnings Call Highlights: Strong ADHD Portfolio Performance ...
  Nov 14, 2025
• Aytu BioPharma Inc. (AYTU) Reports Q1 Loss, Tops Revenue Estimates
  Nov 13, 2025
• Aytu BioPharma to Report Fiscal 2026 First Quarter Operational and Financial Results on November 13, 2025
  Nov 5, 2025
• Aytu BioPharma Announces Patent Term Extension for EXXUA(TM)
  Oct 28, 2025
• Aytu BioPharma to Present at Upcoming October 2025 Conferences
  Oct 10, 2025
• Aytu BioPharma to Present at Upcoming September 2025 Conferences
  Sep 24, 2025
• Aytu BioPharma Inc (AYTU) Q4 2025 Earnings Call Highlights: Strategic Moves and Financial ...
  Sep 24, 2025
• Aytu BioPharma to Report Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results on September 23, 2025
  Sep 16, 2025
• Aytu BioPharma, Inc.'s (NASDAQ:AYTU) Path To Profitability
  Aug 17, 2025
• Lake Street Sees Big Upside for Aytu Biosciences (AYTU) After EXXUA Acquisition
  Jul 22, 2025
• Aytu Boosts Liquidity with Eclipse Loan Extension
  Jul 3, 2025
• Aytu BioPharma Appoints Dr. Gerwin Westfield as Senior Vice President of Scientific Affairs to Support Commercialization of EXXUA(TM)
  Jun 25, 2025
• CEO & Director of Aytu BioPharma Joshua Disbrow Buys 77% More Shares
  Jun 14, 2025
• Aytu BioPharma Announces Closing of Upsized At the Market Public Offering of Common Stock with Full Exercise of Overallotment and Conference Call to Discuss First-in-Class Antidepressant EXXUA(TM) Opportunity and Commercialization Plan
  Jun 9, 2025
• Aytu BioPharma to commercialise Exxua for MDD in the US
  Jun 9, 2025